studi
aim
evalu
environment
air
sampl
altern
form
activ
surveil
respiratori
pathogen
clinic
set
sampl
collect
three
locat
sampl
collect
posit
known
respiratori
pathogen
includ
influenza
influenza
adenoviru
result
suggest
bioaerosol
sampl
may
serv
complement
activ
surveil
clinic
set
addit
sinc
respiratori
virus
detect
aerosol
sampl
result
suggest
hospit
infect
control
measur
includ
use
respir
could
use
limit
spread
infecti
virus
air
emerg
depart
ed
often
frontlin
clinic
care
mani
serious
ill
unabl
seen
acut
primari
care
provid
uninsur
particularli
respiratori
viru
season
influenza
outbreak
ed
task
evalu
treatment
sick
individu
increas
evid
suggest
respiratori
virus
may
transmit
air
novel
surveil
target
bioaerosol
suggest
noninvas
clinic
sampl
techniqu
pilot
studi
studi
bioaerosol
sampl
collect
ed
molecular
evid
respiratori
virus
overal
goal
determin
environment
air
sampl
viabl
altern
method
respiratori
viru
surveil
clinic
set
studi
grant
exempt
review
statu
institut
review
board
duke
univers
ground
research
directli
involv
contact
human
subject
permiss
clinic
supervisor
duke
emerg
depart
obtain
collabor
onduti
care
provid
ensur
order
conduct
studi
duke
univers
hospit
emerg
depart
bioaerosol
sampl
duke
hospit
ed
conduct
studi
personnel
week
octob
march
exclud
holiday
period
begin
decemb
midjanuari
total
separ
sampl
period
yield
aerosol
sampl
test
panel
virus
environment
air
circul
nation
institut
occup
safeti
health
niosh
bc
person
aerosol
sampler
aircheck
sampl
pump
cat
skc
inc
eightyfour
pa
niosh
sampler
featur
two
stage
collect
pathogen
greater
size
polytetrafluoroethylen
ptfe
backup
filter
pore
mm
captur
pathogen
less
produc
three
specimen
sampler
run
pathogen
filter
greater
potenti
remain
viabl
captur
sampler
place
ground
approxim
eyelevel
seat
visitor
three
locat
within
ed
two
sampler
place
duke
ed
wait
room
one
north
south
wing
ed
wait
room
seat
area
third
sampler
setup
one
avail
triag
room
use
rapid
assess
patient
symptom
sampl
pump
calibr
flow
rate
lmin
ran
approxim
min
sampl
session
end
sampl
session
locat
sampl
record
data
time
sampler
number
pump
number
run
time
upon
complet
sampl
period
bioaerosol
sampler
transport
back
duke
one
health
research
laboratori
locat
adjac
build
medic
complex
filter
catchment
contain
process
previous
describ
briefli
filter
catchment
contain
remov
sampler
rins
steril
viru
collect
medium
pb
bsa
aliquot
ml
cryovial
storag
sampl
store
c
molecular
work
perform
focus
pilot
studi
surveil
upon
four
group
preval
respiratori
virus
human
anim
publish
realtim
polymeras
chain
reaction
qpcr
realtim
revers
transcript
polymeras
chain
reaction
qrtpcr
assay
influenza
abcd
virus
human
adenovirus
human
enterovirus
human
coronaviru
use
dna
cdna
posit
control
nucleasefre
water
neg
control
tabl
extract
viral
rna
store
sampl
complet
use
qiamp
viral
rna
mini
kit
qiagen
inc
valencia
ca
test
qrtpcr
assay
use
superscript
r
iii
platinum
onestep
qrtpcr
system
platinum
r
taq
dna
polymeras
thermo
fisher
scientif
inc
waltham
detect
influenza
influenza
b
influenza
c
influenza
human
coronaviru
human
enteroviru
panspeci
coronavirus
detect
gelbas
rtpcr
assay
use
superscript
r
iii
platinum
onestep
rtpcr
system
platinum
r
taq
dna
polymeras
thermo
fisher
scientif
inc
waltham
analysi
specimen
adenoviru
viral
dna
extract
use
qiaamp
dna
blood
mini
kit
qiagen
inc
valencia
ca
examin
real
time
pcr
qpcr
assay
use
sso
advanc
univers
probe
supermix
biorad
hercul
ca
posit
specimen
confirm
use
previous
describ
two
step
molecular
assay
focus
hexon
gene
extract
viral
dna
also
test
detect
panspeci
adenoviru
platinum
r
taq
dna
polymeras
kit
thermo
fisher
scientif
inc
waltham
amplifi
product
hexon
assay
panspeci
assay
submit
eton
bioscienc
eton
bioscienc
inc
raleigh
nc
usa
sequenc
use
bioedit
ibi
bioscienc
carlsband
ca
usa
sequenc
align
edit
compar
nation
center
biotechnolog
inform
ncbi
sequenc
databas
use
blast
applic
octob
march
total
bioaerosol
sampl
collect
three
site
emerg
room
duke
hospit
overal
sampl
indic
evid
least
one
respiratori
pathogen
period
differ
sampl
collect
day
tabl
one
sampl
posit
influenza
viru
one
posit
influenza
viru
sampl
posit
adenoviru
five
adenoviru
posit
specimen
success
sequenc
use
partial
hexon
sequenc
found
either
human
adenoviru
type
report
tabl
adenovirus
detect
frequent
north
wing
ed
wait
room
seat
area
posit
sampl
detect
area
pilot
studi
conduct
aerosol
surveil
human
potenti
zoonot
respiratori
virus
hospit
emerg
room
set
respiratori
virus
detect
aerosol
sampl
addit
one
aerosol
sampl
molecular
evid
influenza
viru
like
rare
event
surveil
abl
detect
molecular
evid
respiratori
pathogen
aerosol
sampl
noninvas
environment
sampl
techniqu
although
tradit
surveil
method
reli
heavili
laboratori
test
clinic
report
diseas
activ
recent
public
indic
type
aerosol
person
sampl
method
may
valid
field
set
similar
wang
et
al
surveil
detect
presenc
adenovirus
aerosol
sampl
virus
rel
hardi
dna
virus
find
unexpect
adenovirus
may
circul
respiratori
viru
season
despit
use
panspeci
molecular
detect
method
find
evid
novel
zoonot
virus
howev
detect
influenza
virus
possibl
zoonot
virus
exclud
despit
given
limit
number
aerosol
sampl
short
period
time
like
lack
sampl
size
detect
airborn
zoonot
virus
hospit
set
found
molecular
detect
influenza
viru
singl
aerosol
sampl
interest
without
valid
cultur
sequenc
valid
similar
detect
among
clinic
ill
patient
interpret
influenza
detect
worthi
public
health
attent
pilot
studi
limit
could
link
aerosol
result
individu
patient
ill
patient
densiti
seen
ed
although
ed
report
patient
respiratori
ill
particular
influenza
b
sampl
period
abl
tempor
link
find
patient
addit
although
focu
studi
detect
viabl
virus
associ
posit
aerosol
sampl
ed
despit
limit
result
studi
indic
aerosol
sampl
use
complement
tradit
sampl
method
find
collect
aerosol
sampl
show
molecular
evid
least
one
respiratori
pathogen
suggest
patient
wait
emerg
room
shed
viru
aerosol
droplet
method
noninvas
rel
low
cost
advantag
environment
sampl
techniqu
high
densiti
area
emerg
room
direct
patient
sampl
difficult
possibl
addit
studi
demonstr
abil
molecularli
detect
airborn
virus
hospit
wait
room
infect
control
procedur
use
respir
sick
patient
consid
inform
molecular
detect
respiratori
virus
hospit
aerosol
use
inform
hospit
practic
prevent
spread
infect
wait
room
studi
transmiss
virus
air
need
determin
potenti
infect
airborn
particl
type
set
jc
jz
sp
collect
analyz
sampl
jc
jz
wrote
introduct
materi
method
eb
wrote
result
discuss
gg
conceiv
idea
studi
help
revis
manuscript
add
import
scientif
content
refin
interpret
result
author
review
final
version
manuscript
agre
submiss
studi
support
duke
univers
discretionari
fund
gray
pi
